Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for …
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Unicycive Therapeutics, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Ambrx Biopharma Inc. | FMP | High | United States | La Jolla | |
| TransCode Therapeutics, Inc. | FMP | High | United States | Boston | |
| Hillstream BioPharma, Inc. | FMP | High | United States | Bridgewater | |
| Cardio Diagnostics Holdings, Inc. | FMP | High | United States | Chicago | |
| SeqLL Inc. | FMP | High | United States | Billerica |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |